HOME >> BIOLOGY >> NEWS
AACR Annual Meeting showcases significant developments in understanding and targeting cancers

re of Cancer Prevention and Cures" featuring world leaders in the fields of cancer genetics, cellular metabolism, stem cell biology, molecular diagnostics, targeted therapies, early detection and the impact of future cancer science on public health will provide a vantage point for historical and current perspectives across the spectrum of basic and applied cancer science. Late-breaking plenary sessions in basic, translational and clinical cancer research will cover the latest advances from the laboratory and their translational potential to the clinic. Special sessions will also feature phase I and phase II studies of novel therapeutic agents in early-stage clinical trials, as well as the latest phase III clinical trial findings.

"This meeting provides an unmatched opportunity to exchange information on current and emerging discoveries, forge new collaborations and identify future opportunities in virtually all areas of modern cancer research and patient care," said Ronald A. DePinho, M.D., scientific chairperson of the 2007 AACR Program Committee. "In our Centennial year, this deeply reflects the intent of our founders on a scale that they could scarcely imagine."

AACRs Annual Meeting attracts attendees including leading academic, industry and government scientists, as well as clinical oncologists, students, cancer survivors, advocates and other health care professionals. Such a diverse group facilitates a cross-disciplinary exchange of new ideas and collaborations. This year, more than 6,000 abstracts were submitted for presentation, complementing an outstanding program of scientific and educational events.

Among meeting highlights, the AACR has selected more than 35 scientific abstracts for presentation by their authors in 10 press briefings, each highlighting a critical or emerging area of cancer research. Featured press briefing topics include:

  • The role of genetics in increasing susceptibility to certa
    '"/>


Contact: Staci Vernick Goldberg
goldberg@aacr.org
267-646-0616
American Association for Cancer Research
10-Apr-2007


Page: 1 2 3

Related biology news :

1. NY Stem Cell Foundations 2nd Annual Translational Stem Cell Research Conference
2. Illinois researchers presenting at ASPB Annual Meeting in Chicago, July 7-11
3. Highlighted sessions of ASBMBs 2007 Annual Meeting
4. Award lectures for ASBMBs 2007 Annual Meeting
5. AACR to present distinguished public service awards at 2007 Annual Meeting
6. New investigators tie for award at the 2007 AIUM Annual Convention
7. Presidential Recognition Awards presented at the 2007 AIUM Annual Convention
8. Advances in personalized medicine on agenda for 54th Society of Nucelar Medicine Annual Meeting
9. AACRs Sixth Annual Landon Awards recognize Richard Kolodner, Douglas Lowy and John Schiller
10. International Society for Heart and Lung Transplantation 27th Annual Meeting and Scientific Sessions
11. Research and program highlights of the 2007 Annual Clinical Genetics Meeting, March 21-25, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... August 06, 2020 , ... ... in the prestigious National STEM Scholar Program, a unique professional development program that ... project support for middle school science teachers nationwide. , Created in partnership between ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... therapeutics product portfolio with a near term focus on Type 2 diabetes and ... commercialization experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin ...
(Date:7/10/2020)... ... 08, 2020 , ... Overcoming Comparability Issues in Regenerative Medicines ... Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy , ... way to complete one? Will the study comply with all FDA requirements? Understanding ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... , ... August 11, 2020 , ... ... year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network ... and 2022. The network is a consortium of academic research centers in the ...
(Date:8/3/2020)... ... 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company ... Known as MediVet Biologics since its formation in 2016, the company is relaunching ... Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... SOMERSET, N.J (PRWEB) , ... July 29, 2020 ... ... editing company, and Catalent, the leading global provider of advanced delivery technologies, development, ... products, today announced that they have entered into a strategic partnership whereby Catalent ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter implantation, ... surgery is only the beginning of a successful study, while protecting and accessing the ... Gien, Global Head of Surgery from Envigo in a live webinar ...
Breaking Biology Technology:
Cached News: